Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.
Saved in:
| Title: | Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al. |
|---|---|
| Authors: | Cesaro S; Pediatric Haematology Oncology, Department of Mother and Child, Azienda Ospedaliera, Universitaria Integrata, Verona, Italy. simone.cesaro@aovr.veneto.it., Ljungman P; Division of Haematology, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Mikulska M; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, and Ospedale Policlinico San Martino, Genova, Italy., Hirsch HH; Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland., Navarro D; Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain., Cordonnier C; University Paris Est-Créteil, Paris, France., Mehra V; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom., Styczynski J; Department of Paediatric Haematology and Oncology, Jurasz University Hospital, Nicolaus Copernicus University Torun, Collegium Medicum, Bydgoszcz, Poland., Marchesi F; Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Pinana JL; Hematology Department, Hospital Clinico Universitario de Valencia; Fundación INCLIVA, Instituto de Investigación Sanitaria, Hospital Clínico, Universitario de Valencia, Valencia, Spain., Beutel G; Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Einsele H; Department of Internal Medicine II, University of Würzburg, Würzburg, Germany., Maertens J; Haematology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium., de la Camara R; Department of Haematology, Hospital de la Princesa, Madrid, Spain. |
| Corporate Authors: | ECIL-10 |
| Source: | Leukemia [Leukemia] 2025 Sep; Vol. 39 (9), pp. 2304-2305. Date of Electronic Publication: 2025 Aug 04. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40759772 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cesaro+S%22">Cesaro S</searchLink>; Pediatric Haematology Oncology, Department of Mother and Child, Azienda Ospedaliera, Universitaria Integrata, Verona, Italy. simone.cesaro@aovr.veneto.it.<br /><searchLink fieldCode="AU" term="%22Ljungman+P%22">Ljungman P</searchLink>; Division of Haematology, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Mikulska+M%22">Mikulska M</searchLink>; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, and Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Hirsch+HH%22">Hirsch HH</searchLink>; Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Navarro+D%22">Navarro D</searchLink>; Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Cordonnier+C%22">Cordonnier C</searchLink>; University Paris Est-Créteil, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mehra+V%22">Mehra V</searchLink>; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Styczynski+J%22">Styczynski J</searchLink>; Department of Paediatric Haematology and Oncology, Jurasz University Hospital, Nicolaus Copernicus University Torun, Collegium Medicum, Bydgoszcz, Poland.<br /><searchLink fieldCode="AU" term="%22Marchesi+F%22">Marchesi F</searchLink>; Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Pinana+JL%22">Pinana JL</searchLink>; Hematology Department, Hospital Clinico Universitario de Valencia; Fundación INCLIVA, Instituto de Investigación Sanitaria, Hospital Clínico, Universitario de Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Beutel+G%22">Beutel G</searchLink>; Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Department of Internal Medicine II, University of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Maertens+J%22">Maertens J</searchLink>; Haematology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22de+la+Camara+R%22">de la Camara R</searchLink>; Department of Haematology, Hospital de la Princesa, Madrid, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ECIL-10%22">ECIL-10</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2025 Sep; Vol. 39 (9), pp. 2304-2305. <i>Date of Electronic Publication: </i>2025 Aug 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40759772 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-025-02721-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2304 Titles: – TitleFull: Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cesaro S – PersonEntity: Name: NameFull: Ljungman P – PersonEntity: Name: NameFull: Mikulska M – PersonEntity: Name: NameFull: Hirsch HH – PersonEntity: Name: NameFull: Navarro D – PersonEntity: Name: NameFull: Cordonnier C – PersonEntity: Name: NameFull: Mehra V – PersonEntity: Name: NameFull: Styczynski J – PersonEntity: Name: NameFull: Marchesi F – PersonEntity: Name: NameFull: Pinana JL – PersonEntity: Name: NameFull: Beutel G – PersonEntity: Name: NameFull: Einsele H – PersonEntity: Name: NameFull: Maertens J – PersonEntity: Name: NameFull: de la Camara R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 39 – Type: issue Value: 9 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |